Strategic Considerations for Pharmaceutical & Medical Device Companies in USPTO Post Grant Proceedings

October 14, 2020


Join McGuireWoods’ intellectual property team for a webinar on strategic considerations for pharmaceutical and medical device companies in litigating post grant proceedings before the U.S. Patent and Trademark Office. Discussion will cover the interplay between inter partes reviews and Hatch-Waxman cases, including proving or rebutting secondary considerations, proving or rebutting that a reference is a printed publication, and assessing issues regarding multiple petitions, parallel proceedings, time bar and estoppel.

McGuireWoods Presenters

  • Benjamin C. Hsing
  • Irene E. Hudson
  • Wanda D. French-Brown

Our programs are intended for the benefit of our clients and contacts and we reserve the right to refuse any registration at our sole discretion.